As global connectivity deepens, it is rapidly and profoundly reshaping the rules of the business world. For enterprises, this era presents both challenges and opportunities. The powerful forces of economic globalization and social diversification have sparked a surging wave of innovation and reform, compelling companies to keep pace with global innovation at the strategic management level.
Hosted by Qingsong Club, co-organized by VCBeat, and supported by Stanford University, Silicon Valley healthcare investors, and major U.S. healthcare industry giants2018U.S. Silicon Valley Medical Innovation Leadership Study Tour, scheduled toDeparted on August 9, 2018.
This study tour features"DecodingUnited StatesInnovative Leadership, DrivingHealthcare Industry Innovation”as the theme, we specially invite Stanford UniversityA professor from the University of California, Berkeley, will provide the most authoritative and cutting-edge insights on innovative leadership in Silicon Valley. The event will also feature executives from Google’s Health Division, Baidu’s U.S. R&D Center, HBI Solutions (a big data healthcare business systems company), and a leading Silicon Valley intellectual property law firm. They will share perspectives on Silicon Valley’s spirit of innovation, corporate incubation, venture capital, and intellectual property protection for healthcare startups, systematically outlining the logic behind Silicon Valley’s healthcare success. This initiative aims to bring top-tier Silicon Valley wisdom and an international perspective to innovators and investors in China’s healthcare industry.
Industry experts join us in systematically examining the logic behind Silicon Valley’s healthcare success; exploring how its innovation ecosystem empowers medical advancements; and analyzing, from multiple perspectives, why Silicon Valley has given rise to groundbreaking healthcare companies such as Genentech, Gilead Sciences, and the da Vinci Surgical System.
The Innovative Power of University Technology Transfer: A Perspective on Industry-Academia-Research Integration and Interdisciplinary Collaboration at Stanford, UCSF, and Berkeley;
Explore how medical incubators with diverse models, such as Johnson & Johnson’s J-Lab, Theranovo, QB3, Triple Ring Technologies, and Stanford SRI, inject market-driven momentum into innovation;
Discussing intellectual property protection strategies and case studies for healthcare innovation enterprises with Berkeley Law School professors and Silicon Valley healthcare-specialized attorneys;
Engage with medical unicorn companies and exchange insights on innovation management and industry perspectives with their founding teams and senior executives;
Discuss industry development trends with renowned biomedicine investors from Silicon Valley and conduct in-depth analysis of U.S. biomedical investment trends;
Networking and resource alignment with the Silicon Valley Baihua Association, the Chinese Biopharmaceutical Association, and local pharmaceutical industry peers;
Four Major Healthcare Themes: A Dialogue with Executives from Industry Giants and Innovative Enterprises
Medical Big Data+AI, Medical Device Innovation, Biopharmaceuticals, and Healthcare Service InnovationVisit unicorn companies across four major healthcare themes and engage in in-depth discussions with their founders or executive teams.
The Founder of the Biotechnology IndustryGenentech J-Lab, Amgen (NASDAQ: AMGN), Gilead Sciences, Pfizer R&D Center, Google Health, Baidu USA R&D Center, HBI Solutions, McKesson Corporation, Stanford University Cross-Border Healthcare Center, IEHP Insurance Company, Silicon Valley neuromodulation medical device company, and the founding team of the da Vinci Surgical System.
Stanford University—Stanford School of Medicine & Department of Bioengineering
UCSF, a Renowned Medical School in the Western United States
University of California, Berkeley
Johnson & Johnson Medical Incubator J-Lab, Triple Ring, Theranova, ……
Visit to a Renowned Intellectual Property Law Firm in Silicon Valley: Discussions with the U.S. Embassy’s Intellectual Property Representative on IP Management for Chinese and American Healthcare Innovation Enterprises

Medical Big Data+AI, Medical Device Innovation, Biopharmaceuticals, and Healthcare Service Innovation: Keynote Speeches by Renowned Investors on Four Major Healthcare Themes;
Silicon Valley Healthcare Investment Forum;
Silicon Valley Medical Project Closed-Door Roadshow;
Customized dinner and small-scale peer exchange on medical themes;
Lumina Club’s Networking Event with the San Francisco Baihua Association and the Chinese Biopharmaceutical Association

1. Target Audience for This Study Tour:
Entrepreneurs seeking to broaden their international perspective and draw on innovative practical experience;
Executives and investors from tech innovation companies who are eager to gain insights into the cutting-edge developments in Silicon Valley and grasp future trends;
2. Some of the trainees who will accompany you include:
Managing Partner of Buchang Asset Management Center, HTInvestment; President of Asia Investment, Fu Yu
Partner/General Manager, Beijing Office, DT Capital Partners
Founding Partner, Danlu Capital
Investment Director, Zhuhai Jafron Biomedical
Chief Operating Officer, Hangzhou Wangji Health Technology Co., Ltd.
Chief Medical Officer, Darma Inc. Shenzhen
Darma Inc. Shenzhen CEO
Senior Project Director, China International Capital Corporation Limited
1、 Time:August 9–17, 2018
2. Number of Participants:15-20 people
3. Fees:88000Yuan/person
Costs Included: All local course fees, company visits, forums and roadshows, meals and transportation, hotel accommodation, overseas travel insurance and service fees; stay in luxury hotels throughout the trip, enjoy local specialty cuisine, and be equipped with translators.
Exclusions: Round-trip international airfare, visa processing fees, and costs for optional private activities.
4. Registration Process:Complete Information — Phone Consultation — Mentor Interview — Confirm Payment. PleaseScan the QR code below to complete your registration. Our staff will contact you within one business day.

5. Inquiry Hotline
Mr. Fu:18580355550
Ms. Fang: 15208495425